-
Pfizer Inc. (PFE $27.22)
- $27.22 P/E (TTM): 15.4X Cap: $154.76B
- View PFE Profile
- View Questions on PFE
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Merck & Company Inc. (MRK $121.93)
- $121.93 P/E (TTM): 15.83X Cap: $302.63B
- View MRK Profile
- View Questions on MRK
-
Pfizer Inc. (PFE $27.22)
- $27.22 P/E (TTM): 15.4X Cap: $154.76B
- View PFE Profile
- View Questions on PFE
Q: Given the sector's relative under performance, I believe the timing is right to increase my portfolio weighting in the Healthcare Sector. I own MRK and PFE. As I started to research individual companies it became apparent my lack of expertise in the area and the pace of technological advance makes stock picking in this area challenging. As such I'm considering an ETF and am currently looking at RSPH. Do you agree with the timing and would you advise an ETF or another individual company? If the former, what do you think of RSPH and if the latter' what would recommend for global exposure to the sector
Thank-you
Any input appreciated,
Thank-you
Any input appreciated,
-
Pfizer Inc. (PFE $27.22)
- $27.22 P/E (TTM): 15.4X Cap: $154.76B
- View PFE Profile
- View Questions on PFE
-
Pfizer CDR (CAD Hedged) (PFE $12.27)
- $12.27 P/E (TTM): 18.79X Cap: $199.85B
- View PFE Profile
- View Questions on PFE
Q: With almost a 7% Dividend, is it a good choice? In TFSA or RRIF to avoid W/H Taxes?
Thanks Kindly!
Thanks Kindly!
-
Pfizer Inc. (PFE $27.22)
- $27.22 P/E (TTM): 15.4X Cap: $154.76B
- View PFE Profile
- View Questions on PFE
-
UnitedHealth Group Incorporated (DE) (UNH $276.65)
- $276.65 P/E (TTM): 14.01X Cap: $250.60B
- View UNH Profile
- View Questions on UNH
-
The Trade Desk Inc. (TTD $27.04)
- $27.04 P/E (TTM): 30.16X Cap: $13.07B
- View TTD Profile
- View Questions on TTD
-
JD.com Inc. (JD $28.07)
- $28.07 P/E (TTM): 7.1X Cap: $40.79B
- View JD Profile
- View Questions on JD
Q: Hello
it was mentioned that Peter would give his thoughts of some of the stocks on TSX that would be candidates for a rebound in 2026, on National Post on Dec 20 , I have missed seeing that, can you let me know what are some of the stocks that he like for a rebound after a disappointing 2025 year? thanks
Michael
it was mentioned that Peter would give his thoughts of some of the stocks on TSX that would be candidates for a rebound in 2026, on National Post on Dec 20 , I have missed seeing that, can you let me know what are some of the stocks that he like for a rebound after a disappointing 2025 year? thanks
Michael
Insiders
Share Information
SEC Filings
News and Media